Literature DB >> 12057882

Issues in design and analysis of a randomized clinical trial to assess the safety of dental amalgam restorations in children.

Timothy A DeRouen1, Brian G Leroux, Michael D Martin, Brenda D Townes, James S Woods, Jorge Leitão, Alexandre Castro-Caldas, Norman Braveman.   

Abstract

The Casa Pia Study of the Health Effects of Dental Amalgams in Children is a randomized clinical trial designed to assess the safety of low-level mercury exposure from dental amalgam restorations in children. It is being carried out in 507 students (8 to 12 years of age at enrollment) of the Casa Pia school system in Lisbon, Portugal, by an interdisciplinary collaborative research team from the University of Washington (Seattle) and the University of Lisbon, with funding from the National Institute of Dental and Craniofacial Research. Since the goal of the trial is to assess the safety of a treatment currently in use, rather than the efficacy of an experimental treatment, unique design issues come into play. The requirements to identify as participants children who have extensive unmet dental treatment needs and who can be followed for 7 years after initial treatment are somewhat in conflict, since those with the most treatment needs are usually in lower socioeconomic categories and more difficult to track. The identification of a primary study outcome measure around which to design the trial is problematic, since there is little evidence to indicate how health effects from such low-level exposure would be manifested. The solution involves the use of multiple outcomes. Since there are concerns about safety, multiple interim comparisons over time between treatment groups are called for which, in conjunction with the use of multiple outcomes, require an extension of statistical methodology to meet this requirement. Ethical questions that have to be addressed include whether assent of the children participating is required or appropriate, and whether the director of the school system, who is the legal guardian for approximately 20% of the students who are wards of the state and live in school residences, should provide consent for such a large number of children. Approaches taken to address these and other design issues are described.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12057882     DOI: 10.1016/s0197-2456(01)00206-9

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  11 in total

1.  Why we need a core outcome set for trials of interventions for prevention and management of caries.

Authors:  Thomas Lamont; Falk Schwendicke; Nicola Innes
Journal:  Evid Based Dent       Date:  2015-09

2.  Genetic polymorphisms of GRIN2A and GRIN2B modify the neurobehavioral effects of low-level lead exposure in children.

Authors:  James P K Rooney; Nancy F Woods; Michael D Martin; James S Woods
Journal:  Environ Res       Date:  2018-04-11       Impact factor: 6.498

3.  Modification of neurobehavioral effects of mercury by genetic polymorphisms of metallothionein in children.

Authors:  James S Woods; Nicholas J Heyer; Joan E Russo; Michael D Martin; Pradeep B Pillai; Federico M Farin
Journal:  Neurotoxicol Teratol       Date:  2013-07-01       Impact factor: 3.763

4.  Modification of neurobehavioral effects of mercury by a genetic polymorphism of coproporphyrinogen oxidase in children.

Authors:  James S Woods; Nicholas J Heyer; Diana Echeverria; Joan E Russo; Michael D Martin; Mario F Bernardo; Henrique S Luis; Lurdes Vaz; Federico M Farin
Journal:  Neurotoxicol Teratol       Date:  2012-07-02       Impact factor: 3.763

5.  Urinary porphyrin excretion in normal children and adolescents.

Authors:  James S Woods; Michael D Martin; Brian G Leroux; Timothy A DeRouen; Mario F Bernardo; Henrique S Luis; Jorge G Leitão; P Lynne Simmonds; Tessa C Rue
Journal:  Clin Chim Acta       Date:  2009-04-24       Impact factor: 3.786

6.  Genetic polymorphisms affecting susceptibility to mercury neurotoxicity in children: summary findings from the Casa Pia Children's Amalgam clinical trial.

Authors:  James S Woods; Nicholas J Heyer; Joan E Russo; Michael D Martin; Federico M Farin
Journal:  Neurotoxicology       Date:  2014-08-07       Impact factor: 4.294

7.  Biomarkers of kidney integrity in children and adolescents with dental amalgam mercury exposure: findings from the Casa Pia children's amalgam trial.

Authors:  James S Woods; Michael D Martin; Brian G Leroux; Timothy A DeRouen; Mario F Bernardo; Henrique S Luis; Jorge G Leitão; John V Kushleika; Tessa C Rue; Anna M Korpak
Journal:  Environ Res       Date:  2008-08-21       Impact factor: 6.498

Review 8.  A systematic review of studies that aim to determine which outcomes to measure in clinical trials in children.

Authors:  Ian Sinha; Leanne Jones; Rosalind L Smyth; Paula R Williamson
Journal:  PLoS Med       Date:  2008-04-29       Impact factor: 11.069

Review 9.  Connecting inorganic mercury and lead measurements in blood to dietary sources of exposure that may impact child development.

Authors:  Renee J Dufault; Mesay M Wolle; H M Skip Kingston; Steven G Gilbert; Joseph A Murray
Journal:  World J Methodol       Date:  2021-07-20

10.  The contribution of dental amalgam to urinary mercury excretion in children.

Authors:  James S Woods; Michael D Martin; Brian G Leroux; Timothy A DeRouen; Jorge G Leitão; Mario F Bernardo; Henrique S Luis; P Lynne Simmonds; John V Kushleika; Ying Huang
Journal:  Environ Health Perspect       Date:  2007-10       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.